Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: N07XX

Dazluma(troriluzole hydrochloride monohydrate)

Spinocerebellar Ataxias

Marketing Authorisation Holder: Biohaven Bioscience Ireland Limited

INN: troriluzole

Indication

Treatment of adult patients with spinocerebellar ataxia genotype 3 (SCA3)

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Dazluma — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.